Aniracetam, also known as aniracetam, belongs to the racetam class brain cell metabolic drug together with piracetam and nafixtam, and is a derivative of piracetam, γ- Lactam brain function improvers selectively act on the brain system and promote and enhance memory function. Compared with piracetam, it has the advantages of strong effect, fast onset and low toxicity.
It can enhance the phospholipase activity in neuronal synapses, increase the formation and transport of ATP in the brain, increase the synthesis of protein and RNA, promote the brain's utilization of amino acids, phospholipids, glucose and oxygen, and increase the patient's reactivity, excitability and memory. It can activate the metabolism of brain cells and protect nerve cells
It is clinically used to treat vascular dementia and Alzheimer's disease with mild and moderate learning, memory and cognitive impairment. It is also used for memory impairment after stroke, benign memory impairment in middle-aged and elderly people and brain retardation in children.